RxDoctor Payments Data

Michael Weber

West Islip, NYNPI 1346472792

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (59.0%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Medtronic at 35.2% of the total.

$215,343in general payments, 2019–2025

Across 189 payments — averaging $1139.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$76K
  • Ablative Solutions, Inc.$59K
  • Idorsia Pharmaceuticals US Inc$41K
  • Janssen Research & Development, LLC$19K
  • Urovant Sciences Inc$10K
  • Kyowa Kirin Co., Ltd$4K
  • plus $6K from 8 others
$83,043in research payments, 2019–2025

Across 75 payments — averaging $1107.23 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$53K
  • Regeneron$30K

What the payments were for

  • Consulting fees$127,03559%
  • Speaking & faculty fees$31,39015%
  • Travel & lodging$52,30624%
  • Food & beverage$4,6122%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Where these figures come from

Is this you, or does something look wrong? →